Afuco™ Anti-IGF1R ADCC Therapeutic Antibody (Dalotuzumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to IGF1R. Dalotuzumab is a humanized monoclonal antibody designed for the treatment of cancers.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-736 |
| Pricing | Inquiry |
| Host | Human |
| Target | IGF1R |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FC, IP, ELISA, Neut, FuncS, IF |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |